LH Valuation

Laboratory Corporation of America Holdings

Add to Watchlist

Advanced Chart

247.660

+6.380(+2.640%)

Overview
Forecast
Valuation

LH Relative Valuation

LH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LH is overvalued; if below, it's undervalued.

Historical Valuation

Laboratory Corporation of America Holdings (LH) is now in the Fair zone, suggesting that its current forward PE ratio of 14.77 is considered Fairly compared with the five-year average of 13.72. The fair price of Laboratory Corporation of America Holdings (LH) is between 206.62 to 277.38 according to relative valuation methord.

Relative Value

Fair Zone

206.62-277.38

Current Price：247.25

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.44

P/B

Median3y

2.20

Median5y

2.32

5.71

FCF Yield

Median3y

5.83

Median5y

6.98

Competitors Valuation Multiple

The average P/S ratio for LH's competitors is 1.28, providing a benchmark for relative valuation. Laboratory Corporation of America Holdings Corp (LH) exhibits a P/S ratio of 1.43, which is 11.82% above the industry average. Given its robust revenue growth of 5.30%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

LH.N

Laboratory Corporation of America Holdings

1.43

Average P/S: 1.28

5.30%